These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7539354)
21. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease. Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271 [TBL] [Abstract][Full Text] [Related]
22. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168 [TBL] [Abstract][Full Text] [Related]
23. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271 [TBL] [Abstract][Full Text] [Related]
24. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412 [TBL] [Abstract][Full Text] [Related]
25. Deletion of the long arm of chromosome 20 in a patient with small cell lymphocytic lymphoma. Cotter PD; Tumewu P; Browett PJ Cancer Genet Cytogenet; 1993 Oct; 70(2):142-3. PubMed ID: 7694789 [TBL] [Abstract][Full Text] [Related]
26. Effect of alemtuzumab on neoplastic B cells. Golay J; Manganini M; Rambaldi A; Introna M Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398 [TBL] [Abstract][Full Text] [Related]
27. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Pittner BT; Shanafelt TD; Kay NE; Jelinek DF Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411 [TBL] [Abstract][Full Text] [Related]
28. [Chronic lymphocytic leukemia in Japan]. Kobayashi T; Kita K; Ohno T; Shirakawa S Rinsho Ketsueki; 1990 May; 31(5):554-63. PubMed ID: 2203917 [TBL] [Abstract][Full Text] [Related]
30. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Momose H; Jaffe ES; Shin SS; Chen YY; Weiss LM Am J Surg Pathol; 1992 Sep; 16(9):859-67. PubMed ID: 1384376 [TBL] [Abstract][Full Text] [Related]
31. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor. Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356 [TBL] [Abstract][Full Text] [Related]
32. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities. Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876 [TBL] [Abstract][Full Text] [Related]
33. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. Pandrau D; Saeland S; Duvert V; Durand I; Manel AM; Zabot MT; Philippe N; Banchereau J J Clin Invest; 1992 Nov; 90(5):1697-706. PubMed ID: 1385474 [TBL] [Abstract][Full Text] [Related]
34. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246 [TBL] [Abstract][Full Text] [Related]
35. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes. Saunders FK; Sharrard RM; Winfield DA; Lawry J; Goepel JR; Hancock BW; Goyns MH Leuk Res; 1993 Mar; 17(3):223-30. PubMed ID: 7680735 [TBL] [Abstract][Full Text] [Related]
36. Phenomena of spontaneous proliferation, differentiation, and apoptosis in primary culture of leukemic lymphocytes. Kalvelyté A; Pabrézaité L Exp Cell Res; 1994 Apr; 211(2):344-52. PubMed ID: 8143782 [TBL] [Abstract][Full Text] [Related]
37. Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages. Hus I; Kawiak J; Tabarkiewicz J; Radej S; Hoser G; Bojarska-Junak A; Schmitt M; Giannopoulos K; Dmoszynska A; Rolinski J Oncol Rep; 2008 Aug; 20(2):443-51. PubMed ID: 18636210 [TBL] [Abstract][Full Text] [Related]
38. Swollen nail folds due to leukemic cell infiltration in a case of chronic lymphocytic leukemia. Saburi Y; Gotoh K; Ohtsuka E; Yamaguchi K Intern Med; 2004 Oct; 43(10):1008. PubMed ID: 15575258 [No Abstract] [Full Text] [Related]
39. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. Tangye SG; Weston KM; Raison RL Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722 [TBL] [Abstract][Full Text] [Related]
40. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells. Secchiero P; Melloni E; Tiribelli M; Gonelli A; Zauli G J Leukoc Biol; 2008 Feb; 83(2):434-7. PubMed ID: 17998303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]